Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report

The paper describes the case of a female patient who had at least three diseases: scleromyxedema, dermatomyositis/polymyositis (DM/PM), and paraproteinemia (monoclonal gammopathy). The concurrence of these diseases determines the atypism of their clinical and morphological patterns, as well as refra...

Full description

Saved in:
Bibliographic Details
Main Authors: M. N. Starovoitova, O. V. Desinova, N. G. Guseva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2015-03-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/595
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849303418953269248
author M. N. Starovoitova
O. V. Desinova
N. G. Guseva
author_facet M. N. Starovoitova
O. V. Desinova
N. G. Guseva
author_sort M. N. Starovoitova
collection DOAJ
description The paper describes the case of a female patient who had at least three diseases: scleromyxedema, dermatomyositis/polymyositis (DM/PM), and paraproteinemia (monoclonal gammopathy). The concurrence of these diseases determines the atypism of their clinical and morphological patterns, as well as refractoriness to performed therapy. Scleromyxedema preceded DM followed by paraproteinemia, which does not rule out its presence in an earlier period when the patent was not carefully examined. The specific feature of this case is scleromyxedema concurrent with DM that was prevalent in the clinical picture of the disease, by determining the severity of the patient’s status and the need to be treated with high-dose glucocorticoids in combination with immunosuppressive drugs. There was no evidence for scleroderma systematica that was supposed to be present in the patient who had scleroderma-like skin involvement.The authors have repeatedly mentioned the concurrency pattern of scleroderma diseases, which reflects the close mechanisms of their development and hinders the identification of specific nosological entities. In this observation, the concurrence of scleromyxedema and DM complements a group of overlap diseases observed in dermatology and rheumatology.Paraproteinemia characteristic of scleromyxedema is occasionally encountered in systemic connective tissue diseases. The patient had monoclonal gammopathy that is most common in scleromyxedema. No signs of myeloma and tumors were seen. Classical paraneoplastic DM/PM was not detected either, which does not rule out the fact that the mechanism responsible for the development of this syndrome and the disease is similar in the patient described.
format Article
id doaj-art-fd985df9bc5c435a81ebf4ee4cba59ed
institution Kabale University
issn 1996-7012
2310-158X
language Russian
publishDate 2015-03-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-fd985df9bc5c435a81ebf4ee4cba59ed2025-08-20T03:59:57ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2015-03-0191444710.14412/1996-7012-2015-1-44-471893Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case reportM. N. Starovoitova0O. V. Desinova1N. G. Guseva2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyThe paper describes the case of a female patient who had at least three diseases: scleromyxedema, dermatomyositis/polymyositis (DM/PM), and paraproteinemia (monoclonal gammopathy). The concurrence of these diseases determines the atypism of their clinical and morphological patterns, as well as refractoriness to performed therapy. Scleromyxedema preceded DM followed by paraproteinemia, which does not rule out its presence in an earlier period when the patent was not carefully examined. The specific feature of this case is scleromyxedema concurrent with DM that was prevalent in the clinical picture of the disease, by determining the severity of the patient’s status and the need to be treated with high-dose glucocorticoids in combination with immunosuppressive drugs. There was no evidence for scleroderma systematica that was supposed to be present in the patient who had scleroderma-like skin involvement.The authors have repeatedly mentioned the concurrency pattern of scleroderma diseases, which reflects the close mechanisms of their development and hinders the identification of specific nosological entities. In this observation, the concurrence of scleromyxedema and DM complements a group of overlap diseases observed in dermatology and rheumatology.Paraproteinemia characteristic of scleromyxedema is occasionally encountered in systemic connective tissue diseases. The patient had monoclonal gammopathy that is most common in scleromyxedema. No signs of myeloma and tumors were seen. Classical paraneoplastic DM/PM was not detected either, which does not rule out the fact that the mechanism responsible for the development of this syndrome and the disease is similar in the patient described.https://mrj.ima-press.net/mrj/article/view/595scleromyxedemadermatomyositis/polymyositisparaproteinemiacase report
spellingShingle M. N. Starovoitova
O. V. Desinova
N. G. Guseva
Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
Современная ревматология
scleromyxedema
dermatomyositis/polymyositis
paraproteinemia
case report
title Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
title_full Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
title_fullStr Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
title_full_unstemmed Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
title_short Scleromyxedema concurrent with dermatomyositis and paraproteinemia: A case report
title_sort scleromyxedema concurrent with dermatomyositis and paraproteinemia a case report
topic scleromyxedema
dermatomyositis/polymyositis
paraproteinemia
case report
url https://mrj.ima-press.net/mrj/article/view/595
work_keys_str_mv AT mnstarovoitova scleromyxedemaconcurrentwithdermatomyositisandparaproteinemiaacasereport
AT ovdesinova scleromyxedemaconcurrentwithdermatomyositisandparaproteinemiaacasereport
AT ngguseva scleromyxedemaconcurrentwithdermatomyositisandparaproteinemiaacasereport